References of Selected Atropine & Animal Studies

1.     Matsumura, H, Hirai, H., Prevalence of myopia and refractive changes in students from 3 to 17 years of age. Surv Ophthalmol. 1999 Oct;44 Suppl 1:S109-115.

 2.     Chou AC, Shih, YF, Ho, TC, Lin, LLK.  The effectiveness of 0.5% atropine in controlling high myopia in children. J Ocul Pharmacol Ther. 1997 Feb;13(1):61-7.

 3.  Dyer, JA, Role of cyclopegics in progressive myopia. Ophthalmology. 1979 May;86(5):692-4.

4.  Coleman, DJ. Unified model for accommodative mechanism. Am J Ophthalmol. 1970 Jun;69(6):1063-79. No abstract available.

5. Romano PE, There's no longer any need for randomized control groups; it's time to regularly offer atropine and bifocals for school myopia; comments on evidence-based medicine.  Binocul Vis Strabismus Q. 2001 Spring;16(1):12.

 6. Shih YF, Hsiao CK, Chen CJ, Chang CW, Hung PT, Lin LL., An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression. Acta Ophthalmol Scand. 2001 Jun;79(3):233-6.

7.     Romano PE, There's no need to risk retinal light toxicity in the medical management of progressive school myopia with atropine (and photochromic bifocals). It is medically indicated.  Binocul Vis Strabismus Q. 2001;16(3):201-2; 227.

 8.     Kennedy RH, Dyer JA, Kennedy MA, Parulkar S, Kurland LT, Herman DC, McIntire D, Jacobs D, Luepker RV. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students. Binocul Vis Strabismus Q. 2000;15(3 Suppl):281-304.

9.     Kennedy RH, Progression of myopia. Trans Am Ophthalmol Soc. 1995;93:755-800.

10.  Grovesnor T. Myopia: what can we do about it clinically? Optom Vis Sci. 1989 Jul;66(7):415-9. Review.
 

11.  Brodstein RS, Brodstein DE, Olson RJ, Hunt SC, Williams RR. The treatment of  myopia with atropine and bifocals. A long-term prospective study. Ophthalmology. 1984 Nov;91(11):1373-9.
 

12.  Bedrossian RH, The effect of atropine on myopia. Ophthalmology. 1979 May;86(5):713-9.
 

13.  Young FA. The nature and control of myopia. J Am Optom Assoc. 1977 Apr;48(4):451-7.
 

14.  Gimbel HV. The control of myopia with atropine. Can J Ophthalmol. 1973 Oct;8(4):527-32.
 

15. Sampson WG. Role of cycloplegia in the management of functional myopia.
Ophthalmology. 1979 May;86(5):695-7.
 

16. Kao SC, Lu HY, Liu JH. Atropine effect on school myopia. A preliminary report.
Acta Ophthalmol Suppl. 1988;185:132-3.

 17. Wesson MD, Bartlett JD, Swiatocha J, Woolley T. Mydriatic efficacy of a cycloplegic spray in the pediatric population. J Am Optom Assoc. 1993 Sep;64(9):637-40.
 

18. Raviola E, Wiesel TN.  The mechanism of lid-suture myopia. Acta Ophthalmol Suppl. 1988;185:91-2.

 19. McBrien NA, Moghaddam HO, Reeder AP.  Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci. 1993 Jan;34(1):205-15.
 

20. Wallman J, Gottlieb MD, Rajaram V, Fugate-Wentzek LA.  Local retinal regions control local eye growth and myopia. Science. 1987 Jul 3;237(4810):73-7.

21. Norton, TT. Experimental myopia in tree shrews. Ciba Found Symp. 1990;155:178-94; discussion 194-9. Review

 22. Zadnik K, Mutti DO.  How applicable are animal myopia models to human juvenile onset myopia? Vision Res. 1995 May;35(9):1283-8. Review.

 23. Christensen AM, Wallman J.  Evidence that increased scleral growth underlies visual deprivation myopia in chicks. Invest Ophthalmol Vis Sci. 1991 Jun;32(7):2143-50.